Most of those that take it detect alterations in how their bodies metabolize sugar
A patient who doesn't respond to semaglutide monotherapy may see dramatic results on tirzepatide because their GIPR variant gives them superior GIP-pathway activation
Medicare coverage for GLP-1 medications is currently very limited unless you have a diagnosis thats not related to weight loss, says Dave Knapp, founder of On the Pen , a community education website about GLP-1s
15% of GLP-1 users have changed a trip plan (flight, dates, schedule) to align with their injection routine
For example, if your vial is reconstituted to 5mg/mL and you need a 2.5mg dose, you draw 50 units (0.5mL)
Evaluation of risk factors for insulin resistance: a cross sectional study among employees at a private university in Lebanon